When we founded Carebot, we started locally. Honestly, like most Czech startups do. Today, our AI is used in hundreds of hospitals across more than ten countries, including the Middle East, and our ambitions go far beyond Central Europe.
Our goal is straightforward but not small. We want AI to become a standard part of healthcare. Not a shiny add-on, but a reliable everyday tool that genuinely helps doctors detect serious diseases earlier and more accurately, from chest X-rays and fractures to complex oncological diagnoses.
We are now opening our largest investment round to date, targeting 8–10 million EUR. The focus is global expansion, stronger commercial and local expert teams, and the ability to scale quickly across very different healthcare systems. We are also actively looking at new products and acquisition opportunities to accelerate our growth.
Demand for AI-driven diagnostics is growing fastest outside Europe. This is not theory for us. We have years of real clinical deployment behind us and a deep understanding of what hospitals actually need in daily practice, from model quality to seamless integrations.
Together with Bristol Myers Squibb, we are already scaling a solution for early cancer detection globally. Based on real-world data, the project was evaluated as one of the top three worldwide. That’s not a local success story anymore.
What started as a CEE AI leader is now shaping the standard of care worldwide.
